OUR MISSION
To build and revolutionise the European cannabis space while fervently committing to creating high quality CBD products for the modern consumer.
Production
100% Swiss Made
Holyworld SA is a leading producer of cannabis-derived CBD products in Switzerland and Europe. We are actively involved in helping modernise the cannabis industry at global scale.
Founded in January 2018 by a group of dynamic entrepreneurs, Holyworld SA is now a subsidiary of one of the world’s biggest cannabis conglomerates: MPXI Corporation. In search of excellence and constant innovation, opportunities are made possible by an emerging global industry where consumer experience is at heart of what we do, ensuring our brands reflect the tastes, preferences and values of current and future customers.
Our crops are certified organic, grown along the shores of Lake Geneva near facilities located between the lake the Alps, and our products are Swiss-made, and tobacco and additive free.
Production
BIO Organic Certified
For more than 3 years, our BIO organic certification guaranties that our cultivation, harvesting, drying, manicuring and curing processes respect intrinsic qualities of the plant and abide to sustainable practices, making our the superior quality products unanimously recognized on the market.
All our Swiss-made and premium quality CBD products are grown, manufactured, and designed for the modern consumer and serve as the forerunners of the industry.
Real time MPXI stock ticker
Award winning
HolyWorld SA is an international subsidiary of the award-winning cannabis pioneer MPXI. Since 2015, MPX Bioceutical has been developing innovative cannabis operations and award-winning products across both consumer and medical industries in North America. The managers of MPX Bioceutical scaled it from a single Licensed Producer into one of the largest vertically-integrated, multi-state operators in the USA.
MPX Bioceutical was acquired in 2019 for $835 million CAD. The sale and subsequent spin-off of MPX International Corporation (MPXI) created the opportunity to replicate the success experienced in North America on a global scale.
It is in our DNA to value sustainability, innovation and quality, and MPXI believes that developing a long-term, international footprint, encompassing all levels of the value chain is key.
Founded MPX Bioceutical in
2015
Retail locations opened
12
Scaled our annual production to
8850kg
Revenue Run-Rate
$100milion+
Debt and Equity Financing
$105million+
Sold in 2018 for
$835million
Founded MPX Bioceutical in
2015
States expanded into
5
Retail locations opened
12
Premium SKUs
145+
Scaled our annual production to
8850kg
Debt and Equity Financing
$105million+
Melting Point Extracts (MPX) is our award-winning cannabis brand, devoted to providing the cleanest and most effective products possible. MPX specializes in Hydrocarbon, CO2, and solvent-free extractions to provide a diverse line of high-quality products including live resin concentrates, wax, sauce, and diamonds.
Meet
OUR TEAM
Management
Alastair Crawford
CEO
Harnoor Grewall
Strategy & Corporate Development
Louis-Philippe Escudié
Business Development
Andrea Bambi
eCommerce
Gail Ford Hills
Retail
Imre Orban
Finance
Directors of Board
Scott Boyes
President
Jeremy Budd
Secretary
Alastair Crawford
Director
Harnoor Grewall
Director
Louis-Philippe Escudié
Director
Strategic Advisors
Harper Dennis Hobbs
Retail
Jean-Marc Levy
Product & Marketing
Rachel Day
Branding & Marketing
Management MPXI
Scott Boyes
CEO and Chairman
Jeremy Budd
Executive Vice President and General Counsel
Jeremy Blumer
CFO
Alastair Crawford
CEO, Europe
Discover
OUR ACTIVITIES
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
